DNA methylation profiles in cancer diagnosis and therapeutics
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
Cancer initiation and proliferation is regulated by both epigenetic and genetic events with epigenetic modifications being increasingly identified as important targets for cancer research. DNA methylation catalyzed by DNA methyltransferases (DNMTs) is one of the essential epigenetic mechanisms that control cell proliferation, apoptosis, differentiation, cell cycle, and transformation in eukaryotes. Recent progress in epigenetics revealed a deeper understanding of the mechanisms of tumorigenesis and provided biomarkers for early detection, diagnosis, and prognosis in cancer patients. Although DNA methylation biomarker possesses potential contributing to precision medicine, there are still limitations to be overcome before it reaches clinical setting. Hence, the current status of DNA methylation biomarkers was reviewed and the future use in clinic was also predicted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Datta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedMGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900
An operational definition of epigenetics: Figure 1.
Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
TET-mediated active DNA demethylation: mechanism, function and beyond
Wu, X., & Zhang, Y. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.33 · Cited by 1,661
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Epigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Dnmt3a is essential for hematopoietic stem cell differentiation
Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1009 · Cited by 1,122
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A., & Cheng, X. (2007) · Nature · doi:10.1038/nature06146 · Cited by 846
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.020 · Cited by 833
Self-citationYan, X.-J., Xu, J., Gu, Z.-H., Pan, C.-M., Lu, G., Shen, Y., Shi, J.-Y., Zhu, Y.-M., Tang, L., Zhang, X.-W., et al. (2011) · Nature Genetics · doi:10.1038/ng.788 · Cited by 813
DNA Methylation in Cancer and Aging
Klutstein, M., Nejman, D., Greenfield, R., & Cedar, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3278 · Cited by 810
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781
Epigenetic Gene Promoter Methylation at Birth Is Associated With Child’s Later Adiposity
Godfrey, K. M., Sheppard, A., Gluckman, P. D., Lillycrop, K. A., Burdge, G. C., McLean, C., Rodford, J., Slater-Jefferies, J. L., Garratt, E., Crozier, S. R., et al. (2011) · Diabetes · doi:10.2337/db10-0979 · Cited by 754
Harris, R. A., Wang, T., Coarfa, C., Nagarajan, R. P., Hong, C., Downey, S. L., Johnson, B. E., Fouse, S. D., Delaney, A., Zhao, Y., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1682 · Cited by 712
Acquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 680
Kaina, B., Christmann, M., Naumann, S., & Roos, W. P. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.03.008 · Cited by 663
MGMT testing—the challenges for biomarker-based glioma treatment
Wick, W., Weller, M., van den Bent, M., Sanson, M., Weiler, M., von Deimling, A., Plass, C., Hegi, M., Platten, M., & Reifenberger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.100 · Cited by 579
Yang, H., Liu, Y., Bai, F., Zhang, J.-Y., Ma, S.-H., Liu, J., Xu, Z.-D., Zhu, H.-G., Ling, Z.-Q., Ye, D., et al. (2013) · Oncogene · doi:10.1038/onc.2012.67 · Cited by 574
How does DNA methylation repress transcription?
Kass, S. U., Pruss, D., & Wolffe, A. P. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01268-7 · Cited by 535
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension
Kaminskas, E., Farrell, A. T., Wang, Y.-C., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-176 · Cited by 490
5-Methylcytosine, Gene Regulation, and Cancer
(1983) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60678-8 · Cited by 422
Lorsbach, R. B., Moore, J., Mathew, S., Raimondi, S. C., Mukatira, S. T., & Downing, J. R. (2003) · Leukemia · doi:10.1038/sj.leu.2402834 · Cited by 416
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss
Klein, C. J., Botuyan, M.-V., Wu, Y., Ward, C. J., Nicholson, G. A., Hammans, S., Hojo, K., Yamanishi, H., Karpf, A. R., Wallace, D. C., et al. (2011) · Nature Genetics · doi:10.1038/ng.830 · Cited by 405
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault, I., Tozlu, S., Lidereau, R., & Bièche, I. (2003) · PubMed · Cited by 397
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Recommendations for the design and analysis of epigenome-wide association studies
Michels, K. B., Binder, A. M., Dedeurwaerder, S., Epstein, C. B., Greally, J. M., Gut, I., Houseman, E. A., Izzi, B., Kelsey, K. T., Meissner, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2632 · Cited by 378
Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene
Chen, W.-D., Han, Z. J., Skoletsky, J., Olson, J., Sah, J., Myeroff, L., Platzer, P., Lu, S., Dawson, D., Willis, J., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji204 · Cited by 370
Nandakumar, V., Vaid, M., & Katiyar, S. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq285 · Cited by 368
Epigenetic Therapeutics: A New Weapon in the War Against Cancer
Ahuja, N., Sharma, A. R., & Baylin, S. B. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-111314-035900 · Cited by 363
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
Targeting DNA methylation for epigenetic therapy
Yang, X., Lay, F., Han, H., & Jones, P. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.001 · Cited by 326
Dunn, J., Baborie, A., Alam, F., Joyce, K., Moxham, M., Sibson, R., Crooks, D., Husband, D., Shenoy, A., Brodbelt, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605127 · Cited by 321
Preferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
Gnyszka, A., Jastrzębski, Z., & Flis, S. (2013) · PubMed · Cited by 318
Ollikainen, M., Smith, K. R., Joo, E. J.-H., Ng, H. K., Andronikos, R., Novakovic, B., Abdul Aziz, N. K., Carlin, J. B., Morley, R., Saffery, R., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq336 · Cited by 312
el-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R. W., Falco, J. P., Hamilton, S. R., & Baylin, S. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3470 · Cited by 310
WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation
Wang, Y., Xiao, M., Chen, X., Chen, L., Xu, Y., Lv, L., Wang, P., Yang, H., Ma, S., Lin, H., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.023 · Cited by 304
Distribution of 5-Hydroxymethylcytosine in Different Human Tissues
Li, W., & Liu, M. (2011) · Journal of Nucleic Acids · doi:10.4061/2011/870726 · Cited by 300
Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1
Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505593200 · Cited by 295
Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., Kotsinas, A., Gorgoulis, V., Field, J. K., & Liloglou, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.23849 · Cited by 290
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
Hsu, C.-H., Peng, K.-L., Kang, M.-L., Chen, Y.-R., Yang, Y.-C., Tsai, C.-H., Chu, C.-S., Jeng, Y.-M., Chen, Y.-T., Lin, F.-M., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.030 · Cited by 281
Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation
Kudo, Y., Tateishi, K., Yamamoto, K., Yamamoto, S., Asaoka, Y., Ijichi, H., Nagae, G., Yoshida, H., Aburatani, H., & Koike, K. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02213.x · Cited by 278
Im, A. P., Sehgal, A. R., Carroll, M. P., Smith, B. D., Tefferi, A., Johnson, D. E., & Boyiadzis, M. (2014) · Leukemia · doi:10.1038/leu.2014.124 · Cited by 267
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy
Winkelmann, J., Lin, L., Schormair, B., Kornum, B. R., Faraco, J., Plazzi, G., Melberg, A., Cornelio, F., Urban, A. E., Pizza, F., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds035 · Cited by 266
SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
Kneip, C., Schmidt, B., Seegebarth, A., Weickmann, S., Fleischhacker, M., Liebenberg, V., Field, J. K., & Dietrich, D. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318220ef9a · Cited by 264
van den Bent, M. J., Dubbink, H. J., Sanson, M., van der Lee-Haarloo, C. R., Hegi, M., Jeuken, J. W. M., Ibdaih, A., Brandes, A. A., Taphoorn, M. J. B., Frenay, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.1034 · Cited by 255
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
Reifenberger, G., Hentschel, B., Felsberg, J., Schackert, G., Simon, M., Schnell, O., Westphal, M., Wick, W., Pietsch, T., Loeffler, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27385 · Cited by 252
The distribution of CpG islands in mammalian chromosomes
Craig, J. M., & Bickmore, W. A. (1994) · Nature Genetics · doi:10.1038/ng0794-376 · Cited by 250
Song, L., James, S. R., Kazim, L., & Karpf, A. R. (2005) · Analytical Chemistry · doi:10.1021/ac0489420 · Cited by 246
DNA methyltransferase and demethylase in human prostate cancer
Patra, S. K., Patra, A., Zhao, H., & Dahiya, R. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10033 · Cited by 234
Jin, Z., Cheng, Y., Gu, W., Zheng, Y., Sato, F., Mori, Y., Olaru, A. V., Paun, B. C., Yang, J., Kan, T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0028 · Cited by 222
TET1 plays an essential oncogenic role in MLL -rearranged leukemia
Huang, H., Jiang, X., Li, Z., Li, Y., Song, C.-X., He, C., Sun, M., Chen, P., Gurbuxani, S., Wang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310656110 · Cited by 220
Self-citationMelotte, V., Lentjes, M. H. F. M., van den Bosch, S. M., Hellebrekers, D. M. E. I., de Hoon, J. P. J., Wouters, K. A. D., Daenen, K. L. J., Partouns-Hendriks, I. E. J. M., Stessels, F., Louwagie, J., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp131 · Cited by 216
Oh, B.-K., Kim, H., Park, H.-J., Shim, Y.-H., Choi, J., Park, C., & Park, Y. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.1.65 · Cited by 203
SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
Schmidt, B., Liebenberg, V., Dietrich, D., Schlegel, T., Kneip, C., Seegebarth, A., Flemming, N., Seemann, S., Distler, J., Lewin, J., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-600 · Cited by 201
Girault, I., Lerebours, F., Amarir, S., Tozlu, S., Tubiana-Hulin, M., Lidereau, R., & Bièche, I. (2003) · PubMed · Cited by 193
Orr, B. A., Haffner, M. C., Nelson, W. G., Yegnasubramanian, S., & Eberhart, C. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041036 · Cited by 176
Oh, T., Kim, N., Moon, Y., Kim, M. S., Hoehn, B. D., Park, C. H., Kim, T. S., Kim, N. K., Chung, H. C., & An, S. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.004 · Cited by 176
Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden, P. A., Metzelaar-Blok, J. A. W., Bergman, W., Monique, H., Hurks, H. M. H., Frants, R. R., Gruis, N. A., & Jager, M. J. (2001) · PubMed · Cited by 168
Liu, C., Liu, L., Chen, X., Shen, J., Shan, J., Xu, Y., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062828 · Cited by 163
DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias
Yang, L., Rodriguez, B., Mayle, A., Park, H. J., Lin, X., Luo, M., Jeong, M., Curry, C. V., Kim, S.-B., Ruau, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.003 · Cited by 162
Gravina, G. L., Festuccia, C., Marampon, F., Popov, V. M., Pestell, R. G., ZANI, B. M., & Tombolini, V. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-305 · Cited by 160
Le, T., Kim, K.-P., Fan, G., & Faull, K. F. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.01.026 · Cited by 153
Quantitative reconstruction of leukocyte subsets using DNA methylation
Accomando, W. P., Wiencke, J. K., Houseman, E. A., Nelson, H. H., & Kelsey, K. T. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r50 · Cited by 146
Valente, S., Liu, Y., Schnekenburger, M., Zwergel, C., Cosconati, S., Gros, C., Tardugno, M., Labella, D., Florean, C., Minden, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4012627 · Cited by 145
Payne, S. R. (2010) · Epigenomics · doi:10.2217/epi.10.35 · Cited by 143
Müller, T., Gessi, M., Waha, A., Isselstein, L., Luxen, D., Freihoff, D., Freihoff, J., Becker, A. J., Simon, M., Hammes, J., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.017 · Cited by 143
Li, L., Li, C., Mao, H., Du, Z., Chan, W., Murray, P. G., Luo, B., Chan, A. T. �., Mok, T. S. K., Chan, F. K. L., et al. (2016) · Scientific Reports · doi:10.1038/srep26591 · Cited by 140
Coronel, J., Cetina, L., Pacheco‐Bravo, I., Trejo‐Becerril, C., González‐Fierro, A., la Cruz-Hernández, E. N. D., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Arias-Bofill, D., Candelaria, M., et al. (2010) · Medical Oncology · doi:10.1007/s12032-010-9700-3 · Cited by 138
Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
Wu, M.-Z., Chen, S.-F., Nieh, S., Benner, C., Ger, L.-P., Jan, C.-I., Ma, L., Chen, C.-H., Hishida, T., Chang, H.-T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3208 · Cited by 137
Aimiuwu, J., Wang, H., Chen, P., Xie, Z., Wang, J., Liu, S., Klisovic, R. B., Mims, A. S., Blum, W. G., Marcucci, G., et al. (2012) · Blood · doi:10.1182/blood-2011-11-382226 · Cited by 137
Kim, H.-J., Kim, J. H., Chie, E. K., DaYoung, P., Kim, I.-A., & Kim, I. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-39 · Cited by 127
A Comparative Epigenomic Analysis of Polyploidy-Derived Genes in Soybean and Common Bean
Kim, K. D., Baidouri, M. E., Abernathy, B. L., Iwata‐Otsubo, A., Chavarro, C. M., Gonzales, M. D., Libault, M., Grimwood, J., & Jackson, S. A. (2015) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.00408 · Cited by 122
Connolly, D., Yang, Z., Castaldi, M. T., Simmons, N., Oktay, M. H., Coniglio, S. J., Fazzari, M. J., Verdier‐Pinard, P., & Montagna, C. (2011) · Breast Cancer Research · doi:10.1186/bcr2924 · Cited by 121
Methylation of the RASSF1A Gene in Human Cancers
Pfeifer, G. P., Yoon, J., Liu, L., Tommasi, S., Wilczynski, S. P., & Dammann, R. (2002) · Biological Chemistry · doi:10.1515/bc.2002.097 · Cited by 120
Gore, S. D., Jones, C. A., & Kirkpatrick, P. N. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2180 · Cited by 119
Dietrich, D., Hasinger, O., Liebenberg, V., Field, J. K., Kristiansen, G., & Soltermann, A. (2012) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e318240503b · Cited by 118
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
Cros, J. F., Hentic, O., Rebours, V., Zappa, M., Gille, N., Théou–Anton, N., Vernerey, D., Maire, F., Lévy, P., Bédossa, P., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0117 · Cited by 112
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis
Zhang, K., Wang, X., Zhou, B., & Zhang, L. (2013) · Familial Cancer · doi:10.1007/s10689-013-9607-1 · Cited by 111
Measuring cell-type specific differential methylation in human brain tissue
Montaño, C. M., Irizarry, R. A., Kaufmann, W. E., Talbot, K., Gur, R. E., Feinberg, A. P., & Taub, M. A. (2013) · Genome Biology · doi:10.1186/gb-2013-14-8-r94 · Cited by 110
Epigenetic-Based Therapies in Cancer: Progress to Date
Song, S., Han, S., & Bang, Y. (2011) · Drugs · doi:10.2165/11596690-000000000-00000 · Cited by 107
Powrózek, T., Krawczyk, P. A., Kucharczyk, T., & Milanowski, J. (2014) · Medical Oncology · doi:10.1007/s12032-014-0917-4 · Cited by 103
Kok, R. M., Smith, D. E. C., Barto, R., Spijkerman, A. M. W., Teerlink, T., Gellekink, H., Jakobs, C., & Smulders, Y. M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.137 · Cited by 102
Loh, K., Chia, J. A., Greco, S., Cozzi, S., Buttenshaw, R. L., Bond, C. E., Simms, L. A., Pike, T., Young, J. P., Jass, J. R., et al. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20552 · Cited by 97
Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers
Deng, D., Liu, Z., & Du, Y. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00005-5 · Cited by 93
High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes
Gonzalez, M. E., Peterson, E. A., Vinnedge, L. M. P., Loffreda-Wren, J. L., Kalikin, L. M., & Petty, E. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1474 · Cited by 87
Das, D. S., Ray, A., Das, A., Song, Y. Y., Tian, Z., Oronsky, B. T., Richardson, P. G. G., Scicinski, J. J., Chauhan, D., & Anderson, K. C. (2016) · Leukemia · doi:10.1038/leu.2016.96 · Cited by 85
Kagan, J., Srivastava, S., Barker, P. E., Belinsky, S. A., & Cairns, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2888 · Cited by 83
Yu, M., Carter, K. T., Makar, K. W., Vickers, K., Ulrich, C. M., Schoen, R. E., Brenner, D. E., Markowitz, S. D., & Grady, W. M. (2015) · Epigenetics · doi:10.1080/15592294.2015.1068490 · Cited by 81
Kawano, H., Saeki, H., Kitao, H., Tsuda, Y., Otsu, H., Ando, K., Ito, S., Egashira, A., Oki, E., Morita, M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3818-z · Cited by 81
Azacitidine in the management of patients with myelodysplastic syndromes
Khan, C., Pathe, N., Fazal, S., LISTER, J. W., & Rossetti, J. M. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712464882 · Cited by 77
Rilova, E., Erdmann, A., Gros, C., Masson, V., Aussagues, Y., Poughon, V., Rajavelu, A., Jeltsch, A., Menon, Y., Novosad, N., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300420 · Cited by 76
Dietrich, D., Jung, M., Pützer, S., Leisse, A., Holmes, E. E., Meller, S., Uhl, B., Schatz, P., Ivascu, C., & Kristiansen, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084225 · Cited by 76
Mastroeni, D., Chouliaras, L., Grover, A., Liang, W. S., Hauns, K., Rogers, J., & Coleman, P. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053349 · Cited by 72
DNA methyltransferases exhibit dynamic expression during spermatogenesis
Uysal, F., Akkoyunlu, G., & Öztürk, S. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.022 · Cited by 72
New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
Gros, C., Fleury, L., Nahoum, V., Faux, C., Valente, S., Labella, D., Cantagrel, F., Rilova, E., Bouhlel, M. A., David‐Cordonnier, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594671 · Cited by 71
Martínez-Galán, J., Torres, B., Moral, R. D., Muñoz‐Gámez, J. A., Martín‐Oliva, D., Villalobos, M., Núñez, M. I., Luna, J. D. D., Oliver, F. J., & de Almodóvar, J. M. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5966 · Cited by 64
DNA methyltransferase inhibitors: an updated patent review (2012-2015)
Xu, P., Hu, G., Luo, C., & Liang, Z. T. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1209488 · Cited by 64
Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia
Man, C. H., Fung, T. K., Wan, H., Cher, C. Y., Fan, A., Ng, N. K. L., Ho, C., Wan, T. S. K., Tanaka, T. T., So, C. W. E., et al. (2015) · Blood · doi:10.1182/blood-2014-06-580993 · Cited by 62
Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic Syndromes
Khan, H., Vale, C., Bhagat, T. D., & Verma, A. K. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.01.001 · Cited by 60
Semaan, A., van Ellen, A., Meller, S., Bergheim, D., Branchi, V., Lingohr, P., Goltz, D., Kalff, J. C., Kristiansen, G., Matthaei, H., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0267-5 · Cited by 60
APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis
Chen, Y., Li, J., Yu, X., Li, S., Zhang, X., Mo, Z., & Hu, Y. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.281 · Cited by 57
Schutter, H. D., Kimpe, M., Isebaert, S. F., & Nuyts, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.032 · Cited by 52
TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.
Hrašovec, S., Hauptman, N., Glavač, D., Jelenc, F., & Ravnik‐Glavač, M. (2013) · Europe PMC (PubMed Central) · doi:10.3233/dma-120948 · Cited by 51
Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer
Rawłuszko-Wieczorek, A. A., Siera, A., Horbacka, K., Horst, N., Krokowicz, P., & Jagodziński, P. P. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1901-2 · Cited by 51
Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis
Peters, S. L., Hlady, R. A., Opavska, J., Klinkebiel, D. L., Pirruccello, S. J., Talmon, G. A., Sharp, J. G., Wu, L., Jaenisch, R., Simpson, M. A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.364 · Cited by 50
Singal, R., Wang, S. Z., Sargent, T. G., Zhu, S. Z., & Ginder, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105580200 · Cited by 49
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
Wang, W., Zhang, L., Wang, Z., Yang, F., Wang, H., Liang, T., Wu, F., Lan, Q., Wang, J., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11726 · Cited by 45
Biomarkers of genome instability and cancer epigenetics
Reis, A. H. O., Vargas, F. R., & Lemos, B. (2016) · Tumor Biology · doi:10.1007/s13277-016-5278-5 · Cited by 43
Yin, A., Zhang, L., Cheng, J., Dong, Y. H., Liu, B.-L., Han, N., & Zhang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085102 · Cited by 42
Kremer, D., Metzger, S., Kolb‐Bachofen, V., & Kremer, D. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.11.033 · Cited by 42
Jung, M., Pützer, S., Gevensleben, H., Meller, S., Kristiansen, G., & Dietrich, D. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0192-7 · Cited by 42
Neri, F., Incarnato, D., Křepelová, A., Parlato, C., & Oliviero, S. (2016) · Nature Protocols · doi:10.1038/nprot.2016.063 · Cited by 40
Fang, C., Wei, X., Zeng, X., Wang, X., Weng, H., & Long, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1926-1 · Cited by 38
Song, X., Huang, F., Liu, J., Li, C., Gao, S., Wu, W., Zhai, M., Yu, X., Xiong, W., Xie, J., et al. (2017) · DNA Research · doi:10.1093/dnares/dsx016 · Cited by 38
Goltz, D., Holmes, E. E., Gevensleben, H., Sailer, V., Dietrich, J., Jung, M., Röhler, M., Meller, S., Ellinger, J., Kristiansen, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10786 · Cited by 36
Tan, K., Kajino, K., Momose, S., Masaoka, A., Sasahara, K., Shiomi, K., Izumi, H., Abe, M., Ohtsuji, N., Wang, T., et al. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.03.002 · Cited by 35
Wijetunga, N. A., Belbin, T. J., Burk, R. D., Whitney, K. D., Abadi, M. A., Greally, J. M., Einstein, M. H., & Schlecht, N. F. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.006 · Cited by 35
Litovkin, K., Joniau, S., Lerut, E., Laenen, A., Gevaert, O., Spahn, M., Kneitz, B., Isebaert, S. F., Haustermans, K. M., Beullens, M., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1738-8 · Cited by 34
Status of RASSF1A in Uveal Melanocytes and Melanoma Cells
Calipel, A., Abonnet, V., Nicole, O., Mascarelli, F., Coupland, S. E., Damato, B. E., & Mouriaux, F. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0437 · Cited by 34
Epigenetic DNA Methylation in Radiation Biology: On the Field or on the Sidelines?
Zielske, S. P. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24959 · Cited by 30
Frycz, B. A., Murawa, D., Borejsza‐Wysocki, M., Marciniak, R., Murawa, P., Drews, M., Kolodziejczak, A. S., Tomela, K., & Jagodziński, P. P. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.12.011 · Cited by 30
Accessing epigenetic variation in the plant methylome
Kim, K. D., Baidouri, M. E., & Jackson, S. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu003 · Cited by 30
Correcting for cell-type composition bias in epigenome-wide association studies
Lowe, R., & Rakyan, V. K. (2014) · Genome Medicine · doi:10.1186/gm540 · Cited by 30
Li, Y., Geng, P., Jiang, W., Wang, Y., Yao, J., Xu, L., Liu, J., Huang, L., Su, B., & Chen, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-1634-5 · Cited by 28
Self-citationChen, Y., Hou, X.-Y., Yang, C., Jiang, X., Yang, M., Xu, X., Feng, S.-X., Liu, Y.-Q., & Jiang, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-4994-1 · Cited by 26
Lim, A. M. L., Candiloro, I. L. M., Wong, N. C., Collins, M. L., Do, H., Takano, E. A., Angel, C. M., Young, R. J., Corry, J. F., Wiesenfeld, D., et al. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-22 · Cited by 25
Li, Y., Hu, Y., Dong, C., Lu, H., Zhang, C., Hu, Q., Li, S., Qin, H., Li, Z., & Wang, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146138 · Cited by 23
Self-citationLi, M., Gao, F., Xia, Y., Tang, Y., Zhao, W., Jin, C., Luo, H., Wang, J., Li, Q., & Wang, Y. (2016) · Scientific Reports · doi:10.1038/srep31826 · Cited by 22
Movérare‐Skrtic, S., Mellström, D., Vandenput, L., Ehrich, M., & Ohlsson, C. (2009) · Endocrine · doi:10.1007/s12020-009-9153-7 · Cited by 20
The role of 5-hydroxymethylcytosine in melanoma
Li, F., Li, L., Zhang, R., Xu, C., Zhou, P., Long, J., Hu, G., & Jiang, M.-J. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000349 · Cited by 17
Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma
Hama, R., Watanabe, Y., Shinada, K., Yamada, Y., Ogata, Y., Yoshida, Y., Tamura, T., Hiraishi, T., Oikawa, R., Sakurai, J., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0462-8 · Cited by 15
Genome-wide DNA methylation profiling in zebrafish
Murphy, P. J., & Cairns, B. R. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.05.002 · Cited by 15
Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination
Guo, D., Myrdal, P. B., Karlage, K. L., O’Connell, S. P., Wissinger, T. J., Tabibi, S. E., & Yalkowsky, S. H. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9383-2 · Cited by 12
Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL
Schmidt‐Wolf, I. G. H., Plass, C., Byrd, J. C., FREVEL, K., Pietsch, T., & Waha, A. (2016) · Anticancer Research · doi:10.21873/anticanres.10998 · Cited by 9
Cited by
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Vasanthakumar, A., Davis, J. W., Idler, K., Waring, J. F., Asque, E., Riley-Gillis, B., Grosskurth, S., Srivastava, G., Kim, S., Nho, K., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00864-y · Cited by 98
Stress and coping in women with breast cancer:unravelling the mechanisms to improve resilience
Borgi, M., Collacchi, B., Ortona, E., & Cirulli, F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.011 · Cited by 90
Recent advances of nucleic acid-based cancer biomarkers and biosensors
Zhao, J., Xia, K., He, P., Wei, G., Zhou, X., & Zhang, X. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215456 · Cited by 44
A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
Zhou, Z., Xu, S., Jiang, L., Tan, Z., & Wang, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.776808 · Cited by 36
Metadata
- Authors
- Pan, Y., Liu, G., Zhou, F., Su, B., & Li, Y.
- Venue
- Clinical and Experimental Medicine
- Published
- 2017-07-27
- Volume
- 18
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1591-8890 (ISSN-L)
- 1591-9528
- OpenAlex
- W2740523213
- Cited by
- 373
- References
- 147
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.